PubMed:33180431
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 1239-1247 | Body_part | denotes | troponin | http://purl.org/sig/ont/fma/fma62338 |
T2 | 1399-1404 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T3 | 1520-1525 | Body_part | denotes | urine | http://purl.org/sig/ont/fma/fma12274 |
T4 | 1543-1548 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 1399-1404 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T2 | 1520-1525 | Body_part | denotes | urine | http://purl.obolibrary.org/obo/UBERON_0001088 |
T3 | 1543-1548 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 39-47 | Disease | denotes | COVID 19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T2 | 190-198 | Disease | denotes | COVID 19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T3 | 225-249 | Disease | denotes | Coronavirus Disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 261-270 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T5 | 346-355 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T6 | 1388-1390 | Disease | denotes | CK | http://purl.obolibrary.org/obo/MONDO_0017941 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 69-73 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | Test |
T2 | 474-478 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T3 | 499-503 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T4 | 816-822 | http://purl.obolibrary.org/obo/NCBITaxon_9005 | denotes | Turkey |
T5 | 917-918 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T6 | 1065-1070 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
T7 | 1163-1167 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | Test |
T8 | 1265-1269 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | Test |
T9 | 1331-1333 | http://purl.obolibrary.org/obo/CLO_0053799 | denotes | 45 |
T10 | 1391-1393 | http://purl.obolibrary.org/obo/PR_000010213 | denotes | MB |
T11 | 1394-1396 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 27 |
T12 | 1399-1404 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T13 | 1399-1404 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T14 | 1474-1476 | http://purl.obolibrary.org/obo/CLO_0053799 | denotes | 45 |
T15 | 1501-1503 | http://purl.obolibrary.org/obo/CLO_0053794 | denotes | 41 |
T16 | 1543-1548 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T17 | 1543-1548 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T18 | 1909-1910 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 1346-1348 | Chemical | denotes | PT | http://purl.obolibrary.org/obo/CHEBI_141395 |
T2 | 1425-1428 | Chemical | denotes | AST | http://purl.obolibrary.org/obo/CHEBI_76649 |
T3 | 1434-1438 | Chemical | denotes | urea | http://purl.obolibrary.org/obo/CHEBI_16199 |
T4 | 1444-1454 | Chemical | denotes | creatinine | http://purl.obolibrary.org/obo/CHEBI_16737 |
T5 | 1460-1473 | Chemical | denotes | triglycerides | http://purl.obolibrary.org/obo/CHEBI_17855 |
T6 | 1479-1485 | Chemical | denotes | sodium | http://purl.obolibrary.org/obo/CHEBI_26708 |
T7 | 1491-1500 | Chemical | denotes | potassium | http://purl.obolibrary.org/obo/CHEBI_26216 |
T8 | 1506-1514 | Chemical | denotes | chloride | http://purl.obolibrary.org/obo/CHEBI_17996 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1388-1393 | http://purl.obolibrary.org/obo/GO_0004111 | denotes | CK-MB |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2 | 39-47 | Disease | denotes | COVID 19 | MESH:C000657245 |
3 | 190-198 | Disease | denotes | COVID 19 | MESH:C000657245 |
19 | 225-249 | Disease | denotes | Coronavirus Disease 2019 | MESH:C000657245 |
20 | 251-259 | Disease | denotes | Covid-19 | MESH:C000657245 |
21 | 261-270 | Disease | denotes | infection | MESH:D007239 |
22 | 346-355 | Disease | denotes | infection | MESH:D007239 |
23 | 559-567 | Disease | denotes | Covid-19 | MESH:C000657245 |
24 | 783-791 | Disease | denotes | Covid-19 | MESH:C000657245 |
25 | 816-822 | Species | denotes | Turkey | Tax:9103 |
26 | 991-999 | Species | denotes | patients | Tax:9606 |
27 | 1434-1438 | Chemical | denotes | urea | MESH:D014508 |
28 | 1444-1454 | Chemical | denotes | creatinine | MESH:D003404 |
29 | 1460-1473 | Chemical | denotes | triglycerides | MESH:D014280 |
30 | 1479-1485 | Chemical | denotes | sodium | MESH:D012964 |
31 | 1491-1500 | Chemical | denotes | potassium | MESH:D011188 |
32 | 1506-1514 | Chemical | denotes | chloride | MESH:D002712 |
33 | 1724-1731 | Species | denotes | patient | Tax:9606 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-57 | Sentence | denotes | Adaptation of Clinical Laboratories to COVID 19 Pandemic: |
T2 | 58-208 | Sentence | denotes | Changes in Test Panels, Overcoming Problems and Preparation Suggestions for Future Pandemics Adaptation of Clinical Laboratories to COVID 19 Pandemic. |
T3 | 209-220 | Sentence | denotes | BACKGROUND: |
T4 | 221-415 | Sentence | denotes | For Coronavirus Disease 2019 (Covid-19) infection, clinical laboratories provide essential contributions in the diagnosis of infection, stage prognostication, and evaluation of disease severity. |
T5 | 416-691 | Sentence | denotes | We aimed to show laboratory problems including changes of test numbers, changes of test panels, and differences of preanalytical errors during Covid-19 pandemic and, in the current study, we also intended to give solutions for the obstacles to guide other possible pandemics. |
T6 | 692-700 | Sentence | denotes | METHODS: |
T7 | 701-772 | Sentence | denotes | Our study was based on data between January 10, 2020, and May 10, 2020. |
T8 | 773-907 | Sentence | denotes | The first Covid-19 case of the Republic of Turkey was seen March 10, 2020, which was determined as the threshold date for comparisons. |
T9 | 908-967 | Sentence | denotes | This was a single center, data mining, retrospective study. |
T10 | 968-976 | Sentence | denotes | RESULTS: |
T11 | 977-1162 | Sentence | denotes | The number of patients admitted to hospital were 34,260 and 15,573, the number of total tests were 66,263 and 42,066 before and after pandemic, respectively, for the two-month interval. |
T12 | 1163-1264 | Sentence | denotes | Test percentage changes were increased for D-dimer 136%, fibrinogen 3,113%, troponin 6%, and LDH 17%. |
T13 | 1265-1561 | Sentence | denotes | Test percentage changes were decreased for CBC 37%, sedimentation 45%, aPTT 30%, PT 37%, CRP 28%, ProCT 10%, ferritin 29%, CK-MB 27%, blood gases 47%, ALT 43%, AST 42%, urea 42%, creatinine 42%, triglycerides 45%, sodium 42%, potassium 41%, chloride 21%, urine culture 58%, and blood culture 44%. |
T14 | 1562-1643 | Sentence | denotes | When preanalytical sources of errors were investigated no differences were found. |
T15 | 1644-1656 | Sentence | denotes | CONCLUSIONS: |
T16 | 1657-1758 | Sentence | denotes | Laboratories must take quick action and be prepared for changes in patient services during pandemics. |
T17 | 1759-1940 | Sentence | denotes | The most reliable ways for this are past experiences, statistical analysis, co-operation with administrations, high quality communication skills, and a risk-based management system. |